Home > Healthcare > Pharmaceuticals > Finished Drug Form > Dermatology Drugs Market

Dermatology Drugs Market Share

Report ID: GMI6311
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Dermatology Drugs Market Share

There are several significant competitors in the highly competitive dermatology drugs companies. The prominent players are

Novartis AG
Amgen Inc.
AbbVie Inc.
Johnson & Johnson
Leo Pharma A/S
Eli Lilly and Company
GlaxoSmithKline Plc
AstraZeneca plc
Pfizer Inc.
Merck KGaA
Lupin
F. Hoffmann-La Roche Ltd.
Sanofi

To keep a competitive advantage in the market, such companies are putting various tactics into practice, including partnerships, mergers, acquisitions, collaborations, and product launches.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Dermatology drugs industry size reached USD 27.1 billion in 2022 and will record USD 73.5 billion by the end of 2032 owing to the increasing prevalence of skin disorders along with the higher advancements in research and development

Parenteral injection route of administration segment is expected to witness 10.5% CAGR from 2023-2032 driven by the rising obligation to offer accurate and targeted medication administration

The hospital pharmacies distribution channel segment held 76.5% of the dermatology drugs industry share in 2022 due to the robust presence of specialized departments as well as diagnostic devices and treatment devices

North America size is expected to be valued at USD 10.7 billion by 2032 driven by the strong presence of well-established and advanced healthcare infrastructure in the region